Form 8-K - Current report:
SEC Accession No. 0001140361-19-021088
Filing Date
2019-11-21
Accepted
2019-11-21 13:16:53
Documents
3
Period of Report
2019-11-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8k.htm 8-K 18945
2 EXHIBIT 4.1 ex4_1.htm EX-4.1 65909
3 EXHIBIT 5.1 ex5_1.htm EX-5.1 9531
  Complete submission text file 0001140361-19-021088.txt   95543
Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

EIN.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-23186 | Film No.: 191236702
SIC: 2836 Biological Products, (No Diagnostic Substances)